fluticasone furoate/vilanterol


( Last Updated : June 18, 2020)
Generic Name:
fluticasone furoate/vilanterol
Project Status:
Withdrawn
Therapeutic Area:
COPD
Manufacturer:
GlaxoSmithKline Inc.
Call for patient/clinician input open:
Brand Name:
Breo Ellipta
Project Line:
Reimbursement Review
Project Number:
SR0524-000
Call for patient/clinician input closed:

Details

Biosimilar:
No
Submission Type:
Resubmission
Indications:
COPD
Date NOC Issued:

Key Milestones2

Call for patient input postedMay 31, 2017
Patient group input closedJuly 20, 2017
Clarification:

- Patient input submission received

Patient input summary sent for review to patient input groupsJuly 25, 2017
Patient group comments on input summary closedAugust 01, 2017
Clarification:

- Patient input summary feedback received

Submission receivedJune 28, 2017
Submission acceptedJuly 13, 2017
Review initiatedJuly 14, 2017
Draft CADTH review report(s) sent to sponsorSeptember 28, 2017
Comments from sponsor on draft CADTH review report(s) receivedOctober 10, 2017
Redaction requests from sponsor on draft CADTH review report(s) receivedOctober 17, 2017
CADTH review team's comments on draft CADTH review report(s) sent to sponsorNovember 03, 2017
Clarification:

- Voluntarily withdrawn by the manufacturer on 2017-Nov-09

Files

Product Monograph